Scott Stanford - Sep 23, 2021 Form 3 Insider Report for Cue Health Inc. (HLTH)

Role
Director, 10%+ Owner
Signature
/s/ Erica Palsis, Attorney-in-Fact of Scott Stanford
Stock symbol
HLTH
Transactions as of
Sep 23, 2021
Transactions value $
$0
Form type
3
Date filed
9/23/2021, 09:06 PM
Previous filing
Jul 2, 2021
Next filing
Sep 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLTH Common Stock 129K Sep 23, 2021 See Footnote F1
holding HLTH Common Stock 194K Sep 23, 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLTH Series A Preferred Stock Sep 23, 2021 Common Stock 5.45M See Footnote F1, F3
holding HLTH Series B Preferred Stock Sep 23, 2021 Common Stock 3.08M See Footnote F1, F4
holding HLTH Series B Preferred Stock Sep 23, 2021 Common Stock 3.83M See Footnote F2, F4
holding HLTH Series C-1 Preferred Stock Sep 23, 2021 Common Stock 1.09M See Footnote F1, F5
holding HLTH Series C-1 Preferred Stock Sep 23, 2021 Common Stock 1.09M See Footnote F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II (as defined below) and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II (as defined below) and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
F2 The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
F3 The Series A Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F4 The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F5 The Series C-1 Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

Remarks:

Exhibit Index: 24.1 Power of Attorney